AsymBio, a subsidiary of Asymchem Group, is a technology-driven global CDMO with operations in Tianjin and Shanghai, specializing in biologics, bioconjugates (ADCs, AOCs, PDCs, RDCs), antibodies and recombinant proteins. We deliver comprehensive end-to-end CDMO services and seamless support spanning from early-stage R&D to commercial-scale manufacturing, backed by a dedicated team of over 600 professionals. With large-scale GMP-compliant biomanufacturing facilities, we adhere to an international quality management system fully aligned with rigorous regulatory requirements across the US, EU and China. As an innovative, reliable and client-centric partner, we are committed to driving your success in the highly competitive pharmaceutical landscape.
AsymBio
AsymBio is a technology-driven global CDMO specializing in biologics, bioconjugates (ADCs, AOCs, PDCs, RDCs), antibodies and recombinant proteins. We deliver comprehensive end-to-end CDMO services from early-stage R&D to commercial-scale manufacturing, backed by GMP-compliant facilities meeting US, EU and China standards.
.avif)
